SUBSCRIBE
SUBSCRIBE

Cell-Based Assays Drive Future of Drug Development: Faster, Cheaper, Better

May 13, 2024 | 
4 min read

Global Cell-Based Assay Market is valued at US$ 19.02 Bn in 2023, and it is expected to reach US$ 35.33 Bn by 2031

Global Cell-Based Assay Market is valued at US$ 19.02 Bn in 2023, and it is expected to reach US$ 35.33 Bn by 2031, with a CAGR of 8.1% during the forecast period of 2024-2031.

A cell-based test, also known as a cellular assay or cell assay, is a technique used in biological research and drug discovery to determine how compounds affect living cells. These tests are critical for studying a variety of biological processes, medication efficacy, toxicity, and mode of action. With the increased demand for new pharmaceuticals to treat a variety of ailments, there is a greater need for effective and reliable tests to identify promising drug candidates.

Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1793

Recent Developments:

  • In August 2022, LifeNet Health LifeSciences launched a new, human-relevant cell-based assay service for drug and compound discovery. These new in vitro screening approaches provide alternatives to animal testing that allow safer, more effective novel compound discovery, bringing a new degree of human relevance and predictability while supporting LifeNet Health’s aim to improving lives via donation.

  • In May 2022, Beckman Coulter Life Sciences introduced the Aquios STEM system, which offers a new approach to stem cell analysis. This innovation greatly improves turnaround time by reducing manual and error-prone stages.

  • In March 2022, Promega Corp. and Fujifilm Cellular Dynamics, Inc. inked an agreement to collaborate on a novel assay development program for drug discovery. The cooperation aims to combine a diverse variety of custom-differentiated cells with Promega’s biosensor and intracellular bioluminescence to facilitate the creation of innovative assays in the drug discovery process.

List of Prominent Players in the Cell-Based Assay Market:

  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Corning Incorporated
  • Lonza Group AG
  • Agilent Technologies, Inc.
  • Promega Corporation
  • PerkinElmer, Inc.
  • Eurofins DiscoverX Products
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings

Market Dynamics:

Drivers:

The increased prevalence of chronic diseases and lifestyle disorders, such as cancer, cardiovascular disease, diabetes, and neurological disorders, is one of the key drivers of market expansion. The growing incidence of cancer worldwide has resulted in the increasing demand for effective medication or treatment, which is likely to fuel the growth of the cell-based assay market throughout the forecast period. Cell-based tests are useful in determining the underlying processes of various disorders and creating targeted treatments.

Challenges:

Implementing cell-based tests can be expensive, requiring specialized equipment, reagents, and expert workers. Some research facilities or organizations with limited financial means may find the initial capital investment and continuous operational expenditures involved with cell culture, assay development, and data processing too expensive. Cell-based assays may require complex procedures, such as cell culture techniques, assay optimization, and data analysis.

Regional Trends:

The North America cell-based assay market is likely to register a significant revenue share and to develop at a rapid CAGR in the near future. The region is expected to expand at a steady rate, maintaining its leadership position during the projected period. Market expansion in the North American region is mostly due to considerable research conducted in various research institutes sponsored by university research institutes and pharmaceutical giants throughout the region.

Segmentation of Cell-Based Assay Market-

Cell-Based Assay Market- By Product

  • Consumables
  • Reagents
    • Assay Kits
    • Microplates
    • Cell Lines
    • Probes and Labels
    • Other Consumables
  • Instruments & Software
  • Services

Cell-Based Assay Market- By Application

  • Drug Screening
  • Basic Research
  • Predictive Toxicology
  • Other Applications

Cell-Based Assay Market- By Technology

  • Flow Cytometry
  • Automated Handling
  • High Throughput Screening
  • High Content Screening
  • Other Technology

Cell-Based Assay Market- By End-User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Other End Users (Government Organizations)

Cell-Based Assay Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Order the 180 Pages Detailed Report @ https://www.insightaceanalytic.com/buy-report/1793

Call: North America +1 551 226 6109 Email: diana.dsouza@insightaceanalytics.com